Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × Injections × Clear all

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT03709550 2022-10-05

Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Phase 1/2 Withdrawn

Genitourinary

Prostatic Neoplasms

Clinical Trials

KEYNOTE F19

Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer